Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
10/2010
10/19/2010US7816349 (R)-3-{3,5-Dichloro-4'-[4-(2-fluoro-ethyl)-piperazine-1-carbonyl]-biphenyl-4-ylmethyl}-1-(4,4-difluoro-cyclohexyl)-pyrrolidin-2-one, used for the treatment of diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome and cognitive disorders
10/19/2010US7816021 4,4-biphenyl-bis/3,5-carbazole derivatives; high efficiency, a low driving voltage, and high brightness
10/19/2010CA2621569C Solid salt forms of a pyrrole substituted 2-indolinone
10/19/2010CA2469346C Substituted 2-pyrrolidin-2-yl-1h-indole derivatives for treatment of migraine
10/19/2010CA2393158C Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
10/19/2010CA2362715C Quinazoline derivatives as angiogenesis inhibitors
10/19/2010CA2271096C Trisresorcinyltriazines
10/19/2010CA2214338C Use of .alpha.1l agonists for treating urinary incontinence
10/14/2010WO2010118367A2 Antiviral pyrimidines
10/14/2010WO2010118286A2 Benzimidazole modulators of h1 receptor and/or ns4b protein activity
10/14/2010WO2010118063A2 Therapeutic compositions and related methods of use
10/14/2010WO2010117977A1 Hepatitis c virus inhibitors
10/14/2010WO2010117932A1 Indole derivatives and methods for antiviral treatment
10/14/2010WO2010117704A1 Hepatitis c virus inhibitors
10/14/2010WO2010117635A1 Hepatitis c virus inhibitors
10/14/2010WO2010117014A1 Triazine derivative
10/14/2010WO2010116594A1 Photoresist material, photoresist film, etching method using same, and novel azo dye compound
10/14/2010WO2010116386A2 Novel polymorph of eletriptan hydrobromide and process for the preparation thereof
10/14/2010WO2010116380A2 A one pot process for preparing 2-butyl-3-[[2'-(1h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1,3-diazaspiro [4, 4] non-1-en-4-one (irbesartan)
10/14/2010WO2010116328A2 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines
10/14/2010WO2010116248A1 Organic compounds and their uses
10/14/2010WO2010115981A1 7-azadispiro [3.0.4.1] decane-8-carboxamides as hepatitis c virus inhibitors
10/14/2010WO2010115736A2 Dihydroorotate dehydrogenase inhibitors
10/14/2010WO2010115719A1 Quinoxaline derivatives and their use for treating benign and malignant tumour disorders
10/14/2010WO2010115548A1 Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereof
10/14/2010WO2010115279A1 Kinase inhibitors and method of treating cancer with same
10/14/2010WO2010095053A3 Apparatus and method of reaching polymers by exposure to uv radiation to produce injectable medical devices
10/14/2010WO2010083384A9 Non-peptidyl, potent, and selective mu opioid receptor antagonists
10/14/2010WO2010077680A3 Compositions of protein receptor tyrosine kinase inhibitors
10/14/2010WO2010068760A3 New 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
10/14/2010WO2010066684A3 Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
10/14/2010WO2010065905A3 Compounds having antiparasitic or anti-infectious activity
10/14/2010WO2010065746A3 Piperazine modulators of nk-1 receptors
10/14/2010WO2010057104A3 Pyridoindole modulators of nmda receptor and acetylcholinesterase
10/14/2010WO2010057088A3 Pyrrolidinyl modulators of nicotinic acetylcholine receptors
10/14/2010US20100261912 Bis-(1(2)h-tetrazol-5-yl)amine and production method therefor
10/14/2010US20100261899 Imidazole compounds
10/14/2010US20100261898 Imidazole compounds
10/14/2010US20100261773 3.3.0 BICYCLIC GlyT1 INHIBITORS AND METHODS OF MAKING AND USING SAME
10/14/2010US20100261761 Novel Sulfonylpyrroles
10/14/2010US20100261743 Novel seh inhibitors and their use
10/14/2010US20100261742 Novel polymorphic forms
10/14/2010US20100261740 Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agent
10/14/2010US20100261732 1, 2, 4 -triazole derivatives as serotonergic modulators
10/14/2010US20100261721 Novel Sulphonylpyrroles
10/14/2010US20100261720 Heterocyclic compound and pharmaceutical composition thereof
10/14/2010US20100261718 N3 alkylated benzimidazole derivatives as mek inhibitors
10/14/2010US20100261717 N3 alkylated benzimidazole derivatives as mek inhibitors
10/14/2010US20100261709 Pyridazinone derivatives as parp inhibitors
10/14/2010US20100261697 2-(heterocyclylbenzyl)pyridazinone derivatives
10/14/2010US20100261696 Sulfonyl-azetidin-3-yl-methylamine amide analogs as glyt1 inhibitors, methods for making same, and use of same in treating psychiatric disorders
10/14/2010US20100261673 Antibacterial compounds and methods of using same
10/14/2010US20100261665 Kinase inhibitor compounds
10/14/2010US20100260750 Novel serotonin reuptake inhibitors as drugs having peripheral-system-restricted activity
10/14/2010US20100260715 Hepatitis c virus inhibitors
10/14/2010US20100260714 Compositions comprising n3 alkylated benzimidazole derivatives as mek inhibitors and methods of use thereof
10/14/2010US20100260708 Hepatitis C Virus Inhibitors
10/14/2010US20100258036 Azo pigment, and pigment dispersion, coloring composition and ink composition for inkjet recording containing the same
10/14/2010DE102009015070A1 New phenyl-pyrimidin-2-yl-amine compounds are tyrosine kinase 2 inhibitors useful for treating e.g. rheumatoid arthritis, Crohn's disease, asthma, multiple sclerosis, adult respiratory distress syndrome, allergic alveolitis and uveitis
10/14/2010CA2758146A1 Organic compounds and their uses
10/14/2010CA2758071A1 Therapeutic compositions and related methods of use
10/14/2010CA2758047A1 Hepatitis c virus inhibitors
10/14/2010CA2757963A1 Hepatitis c virus inhibitors
10/14/2010CA2757654A1 Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereof
10/14/2010CA2757640A1 Indole derivatives and methods for antiviral treatment
10/14/2010CA2757269A1 Hepatitis c virus inhibitors
10/14/2010CA2757138A1 Quinoxaline derivatives and their use for treating benign and malignant tumour disorders
10/14/2010CA2756568A1 Kinase inhibitors and method of treating cancer with same
10/14/2010CA2756542A1 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines
10/13/2010EP2239260A1 Novel compounds with antibacterial activity
10/13/2010EP2238988A1 Conjugated prodrugs of cc-1065 analogs
10/13/2010EP2238128A2 Heterocyclic pyrazole-carboxamides as p2y12 antagonists
10/13/2010EP2238127A2 Pyrazole-carboxamide derivatives as p2y12 antagonists
10/13/2010EP1994011B1 Sulfonyl benzimidazole derivatives
10/13/2010EP1937667B1 Benzimidazoles useful as inhibitors of protein kinases
10/13/2010EP1891056B1 Novel compounds
10/13/2010EP1370537B1 Metalloproteinase inhibitors
10/13/2010CN101861313A Phenyl amino pyrimidine compounds and uses thereof
10/13/2010CN101861312A 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines and pyridines and 3-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-2-phenyl pyridines as 5-HT7 receptor antagonists
10/13/2010CN101861302A Pyrrolidine aryl-ether as NK3 receptor antagonists
10/13/2010CN101857589A Pyrazol-benzimidazoles derivative and application thereof
10/13/2010CN101133036B Novel benzimidazole derivatives useful as selective androgen receptor modulators (SARMS)
10/13/2010CN101054372B Pyrimidine substituted benzenepropanoic acid derivative, its preparation method and use in curing polycystic kidney disease
10/12/2010US7812160 G-protein-coupled chemoattractant receptor, expressed on T helper cells antagonists such as [4-(dimethylamino)-2-(4-{[4-(trifluoromethyl)benzoyl]amino}benzyl)-5-pyrimidinyl]acetic acid;, used for the treatment of allergic diseases, inflammatory diseases, eosinophil- and basophil-related diseases
10/12/2010US7812158 Coupling agents for peptide synthesis
10/12/2010US7812043 {2-[(1-cyclopropylmethyl-6-fluoro-1H-indole-3-carbonyl)-amino]-thiazol-5-ylsulfanyl}-acetic acid, used for treating non-insulin dependent diabetes, dyslipidemia, hyperlipidemia, hypertension, obesity and as dietetics
10/12/2010US7812038 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid
10/12/2010US7812036 Androgens
10/12/2010US7812026 Imidazole derivatives having a positive allosteric GABAB receptor modulator effect and methods of use
10/12/2010US7812025 neuroprotectants such as 4-biphenyl-3-yl-N-pyridin-3-ylpiperazine-1-carboxamide effective in prevention and treatment of cerebrovascular disorders such as necrosis, hemorrhages, injuries, as antidepressants and/or anxiolytic agents
10/12/2010US7812021 {(3RS,4SR)-3-(3,4-dichloro-phenyl)-4-[(RS)-1-(4-trifluoromethyl-phenoxy)-ethyl]-pyrrolidin-1-yl}-(4-methanesulfonyl-piperazin-1-yl)-methanone, for the treatment of depression, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder
10/12/2010US7812017 such as 1-(Phenylsulfonyl)-4-(piperazin-1-ylmethyl)-1H- indole, hydrochloride, used as dietetics, selective serotonin receptor antagonists or in cosmetics
10/12/2010US7812016 HIV integrase inhibitors such as 5-(1,1-Dioxido-1,2-thiazinan-2-yl)-7[5-(4-fluorobenzyl)-1,3,4-oxadiazol-2-yl]-1,6-naphthyridin-8-ol, useful in the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC
10/12/2010CA2476164C Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity
10/12/2010CA2467838C Pyrimidine derivatives as modulators of insuline-like growth factor-1 receptor (igf-i)
10/12/2010CA2419552C Substituted pyrazoles
10/12/2010CA2223062C 3-pyridyloxyalkyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
10/07/2010WO2010115125A2 Composition of 2,4,6-trifluoro-n-[6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl]-benzamide
10/07/2010WO2010114957A1 Bicyclic piperidine and piperazine derivatives as gpcr modulators for the treatment of obesity, diabetes and other metabolic disorders
10/07/2010WO2010114179A1 3-[1,4]oxazepane-4-pyrimidone derivatives
1 ... 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 ... 626